lm11a-31 and Infarction--Middle-Cerebral-Artery

lm11a-31 has been researched along with Infarction--Middle-Cerebral-Artery* in 1 studies

Other Studies

1 other study(ies) available for lm11a-31 and Infarction--Middle-Cerebral-Artery

ArticleYear
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves Recovery.
    The Journal of pharmacology and experimental therapeutics, 2022, Volume: 380, Issue:2

    The aim of this study was to test whether poststroke oral administration of a small molecule p75 neurotrophin receptor (p75

    Topics: Animals; Brain; Glutathione; Glycolysis; Infarction, Middle Cerebral Artery; Isoleucine; Mice; Mice, Inbred C57BL; Morpholines; Neuroprotective Agents; Neurotransmitter Agents; Receptor, Nerve Growth Factor

2022